| Bioactivity | Aliskiren-d6 (hemifumarate) is a deuterium labeled Aliskiren hemifumarate. Aliskiren hemifumarate is a direct and orally active renin inhibitor with an IC50 of 1.5 nM[1][2]. |
| Target | IC50: 1.5 nM (renin) |
| Name | Aliskiren-d6 (hemifumarate) |
| Formula | C32H49D6N3O8 |
| Molar Mass | 615.83 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yuji Nakamura, et al. Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor. ACS Med. Chem. Lett., 2012, 3 (9), pp 754-758. [2]. Buczko W, et al. Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor. Pharmacol Rep. 2008 Sep-Oct;60(5):623-31. |
Aliskiren-d6 (hemifumarate)
CAS: F: C32H49D6N3O8 W: 615.83
Aliskiren-d6 (hemifumarate) is a deuterium labeled Aliskiren hemifumarate. Aliskiren hemifumarate is a direct and orally
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.